- TWD2.62bn
- TWD3.45bn
- TWD3.81bn
- 23
- 70
- 52
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,123 | 5,374 | 5,914 | 4,438 | 3,813 |
Cost of Revenue | |||||
Gross Profit | 904 | 1,197 | 644 | 450 | 350 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5,484 | 4,515 | 5,599 | 4,322 | 4,229 |
Operating Profit | 639 | 858 | 315 | 117 | -417 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 595 | 919 | 269 | 87 | -477 |
Provision for Income Taxes | |||||
Net Income After Taxes | 463 | 732 | 238 | 60.2 | -392 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 463 | 738 | 260 | 54.5 | -378 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 463 | 738 | 266 | 59.3 | -378 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.27 | 10.3 | 2.86 | 0.661 | -4.58 |
Dividends per Share |